News & Events about Organon Co.
Organon (NYSE: OGN), a global womens healthcare company, today announced a strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy. The agreement also grants Organon...
DARE-PDM1 Utilizes Proprietary Hydrogel Technology for Vaginal Delivery of Diclofenac, a Nonsteroidal Anti-Inflammatory; Phase 1 Study Targeted for 2023 2022 Dar Portfolio Accomplishments Include: Two Additional Portfolio Programs (DARE-GML and grant-funded DARE-LBT); License Agreement with Organon ...
Organon (NYSE: OGN), a global womens healthcare company, today announced that Kirke Weaver has been appointed General Counsel and Corporate Secretary, and will continue as a member of Organons executive leadership team, effective January 1, 2023. Mr. Weaver was named as the interim head of the...
Ticker Report
3 months ago
ProShare Advisors LLC reduced its position in shares of Organon Co. (NYSE:OGN Get Rating) by 22.5% in the 2nd quarter, according to its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 55,771 shares of the companys stock ...
Organon and Flat6Labs Announce Winners of MENA Region's First Digital-Health FemTech Accelerator Organon and Flat6Labs Announce Winners of MENA Region's First Digital-Health FemTech Accelerator PR Newswire CAIRO, Sept. 13, 2022 - 'Omgyno' founded by Doreen Toutikian and Elisabeth Milini in Greece...